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ABSTRACT
Objectives: Optimization, isolation, and characterization of bioactive compounds from Streptomyces lavendulocolor VHB-9 isolated from granite 
mines of Mudigonda village of Khammam district of Telangana state.
Methods: The potent strain was identified as S. lavendulocolor VHB-9 by polyphasic taxonomy. The influence of culture conditions on growth and 
bioactive compounds production was investigated. Purification of bioactive compounds was done using column chromatography. The structures 
of the compounds were elucidated on the basis of spectroscopic analysis including Fourier transform infrared, electron spray ionization mass 
spectrophotometry,1H nuclear magnetic resonance (NMR), and13C NMR. The antimicrobial activity of the compounds produced by the strain was 
tested against both Gram-positive and Gram-negative bacteria and fungi in terms of minimum inhibitory concentration.
Results: Isolation and identification of two compounds, namely (2R, 3R)-2, 3-Butanediol (B1A), and nonadecanoic acid (B1B). Fraction B4 was 
isolated partially purified fraction and identified by the gas chromatography-mass spectrometry analysis. B1B compound exhibited the highest 
activity against Bacillus megaterium, Staphylococcus aureus, Bacillus subtilis, Pseudomonas aeruginosa, and Candida albicans when compared to B1A 
and B4 compounds.
Keywords: Granite mine, Streptomyces lavendulocolor, Optimization, Spectroscopy, Gas chromatography-mass spectrometry analysis, Biological assay.
INTRODUCTION
Natural products have been the largest contributors to drugs in the 
history of medicine. Microorganisms are attractive resources to 
synthesize structurally-diverse substances with various bioactivities 
that may be used as effective drugs or act as drug lead compounds 
that could be further modified and developed for higher efficacy [1]. 
Within the domain bacteria, actinomycetes showed unprecedented 
ability to produce potentially novel, clinically useful, secondary 
metabolites with anticancer, antioxidant, antiviral, and antibacterial 
compounds, the majority of these being derived from the members 
of the Streptomyces genus that include different classes of antibiotics 
including aminoglycosides, macrolides, and Beta-lactams [2].
Newer therapeutic agents such as daptomycin, linezolid, and 
streptogramin combination (quinupristin/dalfopristin) have entered 
the clinical area in the past few years to combat the multidrug-
resistant bacteria [3]. However, certain undesirable side effects and 
the spread of pathogens with this new antimicrobial drug resistance 
emphasize the need for the development of other newer antimicrobial 
agents with activity against Gram-positive bacteria, Gram-negative 
environmental, and enteric organisms currently threaten patients 
in hospitals and communities with multidrug resistance [4]. The end 
result of this phenomenon is that many strains of bacteria have become 
resistant, and in many cases multi-resistant to these therapeutic 
agents, thus rendering these drugs ineffective as treatments of choice 
for severe infections caused by these pathogens [5]. Rising numbers 
of antibiotic unresponsive infectious disease agents confront patients 
worldwide [6], and consensus has emerged that it is essential that novel 
antibiotic classes be developed as part of the strategy to control the 
emerging drug-resistant pathogens.
Filamentous soil bacteria belonging to the genus Streptomyces are 
widely recognized as industrially important microorganisms and 
versatile producers of new secondary metabolites from different 
biosynthetic pathways, originate from different ecological niches 
that could be used to hunt for novel bioactive compounds. The great 
importance given to Streptomyces is partly because these are among 
the most numerous and most versatile soil microorganisms, given 
their large metabolite production rate and their biotransformation 
processes, their capability of degrading lignocellulose and chitin, and 
their fundamental role in biological cycles of organic matter. Indeed, 
different Streptomyces species produce about 75% of commercially 
and medically useful antibiotics. They have provided more than half 
of the naturally occurring antibiotics discovered to date and continue 
to be screened for useful compounds [7]. In the course of screening 
for new antibiotics, several studies are oriented toward isolation of 
Streptomycetes from different habitats.
In the view of that the strain S. lavendulocolor VHB-9 was isolated from 
a granite mine of Mudigonda village of Khammam district of Telangana 
state, India. An attempt was made in the present study to optimize the 
cultural parameters required for best yields of bioactive metabolites, 
and chemical characterization of the compounds was also investigated.
METHODS
Chemicals
All solvents, reagents, and media supplements used in this study were 
of extra pure grade and procured from Merck (Mumbai, India).
Strain isolation
The strain, S. lavendulocolor VHB-9, was isolated on yeast extract-malt 
extract-dextrose (YMD) agar medium by soil dilution technique from 
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a soil sample collected from granite mines of Mudigonda, Khammam 
District, Telangana state, India. The medium was composed of malt 
extract (1%), yeast extract (0.4%), dextrose (0.4%), CaCO3 (0.2%), and 
agar (2.0%), pH 7.0±0.2. The strain was stored on YMD agar slants at 
4°C.
Antimicrobial profile of bioactive metabolites produced by the 
strain
The antimicrobial profile of the strain S. lavendulocolor VHB-9 was 
studied by cultivating the strain in YMD broth at 30°C for 8 days. The 
antimicrobial activity of bioactive metabolites against Staphylococcus 
aureus (MTCC 3160), Lactobacillus casei, Bacillus megaterium (NCIM 
2187), Proteus vulgaris (ATCC 6380), Pseudomonas aeruginosa (ATCC 
9027), Escherichia coli (ATCC 9027), Aspergillus niger, Fusarium solani, 
Fusarium oxysporum, and Candida albicans (MTCC 183) was determined 
by agar well diffusion assay, and inhibition zones against test microbes 
were determined [8].
Media optimization
Attempts were made to enhance the antimicrobial activity of 
S. lavendulocolor VHB-9 by optimizing the culture conditions such 
as pH, temperature, carbon sources, nitrogen sources, and minerals. 
The bioactive metabolite production of the strain was determined 
after 4 days of incubation. Fermentation was carried out in 250-mL 
Erlenmeyer flasks with constant shaking at 180 rpm. The effect of initial 
pH on the bioactive metabolite production was determined by adjusting 
pH of the production medium from 4 to 10. The optimal pH achieved 
at this step was fixed for further study [9]. Similarly, the optimum 
temperature for antimicrobial metabolite production was determined 
by incubating the strain at temperatures ranging from 20 to 40°C, while 
maintaining all other conditions at optimum levels [10]. The effect of 
carbon sources on bioactive metabolite production was determined by 
supplementing the production medium (YMD) with different carbon 
sources such as maltose, sucrose, mannitol, lactose, starch, cellulose, 
galactose, sorbitol, and fructose each at a concentration of 0.4% 
(w/v) replacing dextrose by keeping the other ingredients constant 
[11]. Influence of varying concentrations of the best carbon source 
(0.5–4% w/v) on bioactive metabolite production was also investigated.
Similarly, the influence of various nitrogen sources such as sodium nitrate, 
ammonium oxalate, ammonium sulfate, peptone, tryptophan, L-proline, 
tyrosine, urea, and yeast extract was studied by adding nitrogen source 
(0.4%) to the medium with an optimized carbon source. Further, the 
optimal levels of the suitable nitrogen source (0.1–1.5% w/v) for good 
yields of bioactive metabolites were also recorded [12]. To evaluate the 
effect of mineral salts, the optimized medium containing the superior 
carbon and nitrogen source was supplemented separately with mineral 
supplements such as KH2PO4, K2HPO4, NaCl, KCl, MgSO4.7H2O, FeSO4.7H2O, 
and MnCl2 at a concentration of 0.05% (w/v) [13].
Extraction of the metabolite and antimicrobial activity assay
The strain S. lavendulocolor VHB-9 grown under optimized cultural 
conditions for 4 days was extracted with ethyl acetate, and concentrated 
in a rotary evaporator to obtain a crude extract. The antimicrobial 
metabolites produced were tested by agar well diffusion assay against 
the following test microorganisms:
Bacteria
Overnight grown cultures of S. aureus (MTCC 3160), Bacillus subtilis 
(ATCC 6633), B. megaterium (NCIM 2187), Shigella flexneri (MTCC 1457), 
L. casei (MTCC 1423), Lactobacillus acidophilus (MTCC 495), Proteus 
vulgaris (MTCC 7299), P. aeruginosa (ATCC 9027), E. coli (ATCC 35218), 
Vibrio cholerae, and Streptococcus mutans (MTCC 497) were used.
Fungi
C. albicans (ATCC 10231), A. niger, Aspergillus flavus, F. solani, 
F. oxysporum (MTCC 3075), Penicillium citrinum, and Alternaria sp. were 
used as test fungi for testing antifungal activity.
Extraction, purification, and characterization of antimicrobial 
compounds
Fermentation
A seed culture was prepared by culturing S. lavendulocolor VHB-9 in 
YMD broth and incubated on a rotary shaker (180 rpm) at 30°C for 48 h. 
The seed culture was then transferred to fermentation broth containing 
malt extract - 1%, lactose - 0.5%, peptone - 0.5%, and K2HPO4 - 0.05% 
with pH adjusted to 7 and incubated on rotary shaker (180 rpm) at 30°C 
for 120 h. The bioactive compounds from the fermented broth were 
harvested by filtration of biomass through Whatman Filter Paper No. 42 
(Merck, Mumbai, India). The culture filtrate (30 L) was extracted twice 
with an equal volume of ethyl acetate, pooled and the organic layer 
was concentrated in a Rotavac. The deep brown semi-solid compound 
(3.0 g) obtained was applied to a silica gel G column (25 cm×5 cm, Silica 
gel, Merck, Mumbai, India).
The separation of the crude extract was carried out through gradient 
elution system of hexane: ethyl acetate. The eluent was run over the 
column, and small volumes of eluent collected in test tubes were 
analyzed through thin-layer chromatography (TLC) using silica gel 
plates (Silica gel, Merck, Mumbai, India) with hexane: ethyl acetate 
solvent system [14]. Compounds with identical retention factors (Rf) 
were combined and assayed for antimicrobial activity against Gram-
positive (B. megaterium), Gram-negative (E. coli) bacteria, and yeast 
(C. albicans) by using agar well diffusion assay [15].
Among the different fractions, two fractions B1 (polar) and 
B4 (nonpolar) were collected at gradient solvent system of 
Hexane: ethyl acetate (70-30v/v and 90-10v/v). The B1 fraction was 
rechromatographed (22 X 2.5 cm, Silica gel 100; Merck) to get two 
pure compounds ((2R, 3R)-2, 3-Butanediol (B1A), and nonadecanoic 
acid [B1B]). The structures of these active fractions were analyzed on 
the basis of Fourier transform infrared (FTIR); model: Thermo Nicolet 
Nexus 670 spectrophotometer with NaCl optics and electron ionization 
mass/electron spray ionization mass spectrophotometry (EIMS/
ESIMS); model: Micromass VG - 7070H, 70eV spectrophotometer and 
nuclear magnetic resonance (NMR) (1H NMR and13C NMR) model: 
Varian Gemini 200 and samples were made in CDCl3 with trimethyl 
saline as standard.
Fractions B4 obtained as a mixture of compounds analyzed on Agilent 
gas chromatography-mass spectroscopy (GC-MS) system. The fused 
silica HP-5 capillary column (30 m×0.25 mm, ID, film thickness of 
0.25 μm) was directly coupled to the MS. The carrier gas was helium 
with a flow rate of 1.2 ml/min. Oven temperature was programmed 
(50°C/min), then 50–280°C (at rate of 5°C/min) and subsequently 
held isothermally for 20 min. The temperature of the injector port was 
maintained at 250°C and that of the detector at 280°C [16]. The peaks 
of components in gas chromatography were subjected to mass spectral 
analysis. The spectra were analyzed from the available library data 
NIST MS search (ver. 2.0) (Included with NIST’02 mass spectral library, 
Agilent p/n G 1033 A).
Biological assays
Minimum inhibitory concentration (MIC)
The MIC of antimicrobial metabolites produced by the strain was 
determined against Gram-positive as well as Gram-negative bacteria 
and fungi using agar plate well-diffusion assay [15]. Nutrient agar 
and Czapek-Dox agar media were used for culturing bacteria and 
fungi, respectively. Sterilized agar medium seeded with the test 
bacterial suspension was transferred to Petri plates under aseptic 
conditions. After the solidification of agar medium, wells about 6mm 
diameter were cut into it with a sterilized cork borer. In case of the 
antifungal assay, test fungus (105 spores/ml) was plated on to the 
solidified agar medium. Metabolites dissolved in dimethyl sulfoxide 
(DMSO) at concentrations ranging from 0 to 1000 µg/ml were added 
to the wells.
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After inoculation the plates were incubated at 30°C and examined 
after 24–48 h of incubation for bacteria and 48–72 h for yeast and 
filamentous fungi. The experiment was carried out in triplicates, and 
the solvent (DMSO) alone was kept as a negative control. Tetracycline 
and Carbendazim were employed as positive controls for bacteria and 
fungi, respectively. The lowest concentration of the bioactive compound 
exhibiting antimicrobial activity against the test microbes was taken as 
MIC of the compound.
The MICs of the bioactive compounds (B1A, B1B, and B4) produced by 
the strain were determined against several opportunistic pathogenic 
bacteria and fungi.
Test organisms employed
The cultures of S. aureus (MTCC 3160), B. megaterium (NCIM 2187), 
B. subtilis (ATCC 6633), Serratia marcesens (MTCC 1457), Xanthomonas 
campestris (MTCC 2286), P. vulgaris (MTCC 7299), P. aeruginosa 
(ATCC 9027), E. coli (ATCC 35218), Enterococcus faecalis (MTCC 439), 
S. mutans (MTCC 497), L. casei (MTCC 1423), and L. acidophilus (MTCC 
495) were employed for antibacterial assay. C. albicans (ATCC 10231), 
A. niger (ATCC 1015), A. flavus (ATCC 9643), F. solani (MTCC 4634), 
F. oxysporum (MTCC 3075), and Penicillium citrinum (MTCC 6489) were 
used for testing antifungal activity.
Statistical analysis
The results of bioactive metabolite production by S. lavendulocolor 
VHB-9 under different cultural conditions were statistically analyzed 
with one-way analysis of variance (ANOVA).
RESULTS AND DISCUSSION
Antimicrobial profile of bioactive metabolites produced by the 
strain
The growth pattern of S. lavendulocolor VHB-9 cultured in YMD broth 
was reported on our earlier publication [17]. The strain entered log 
phase after 24 h of incubation and exhibited exponential growth up 
to 96 h followed by stationary phase extended up to 120 h. The crude 
extract obtained from a 4-day-old culture exhibited high antimicrobial 
activity against the test microorganisms (Fig. 1). A previous report 
demonstrated high antimicrobial activity of crude extracts of a 4-day-
old culture of Arthrobacter kerguelensis VL-RK_09 [18]. The metabolites 
collected from 4-day-old culture of Streptomyces griseus exhibited good 
antifungal activity [19]. Similarly, the extracts of 4-day-old cultures of 
Streptomyces psammoticus [20], Streptomyces tendae TKVL_ 333 [21], 
and Nocardia levis MK-VL_113 [22] were active against test bacteria and 
fungi.
Crude extracts of 5-day-old cultures of Streptomyces purpeofuscus [23] 
and Streptomyces albidoflavus [24] were active against Gram-positive 
as well as Gram-negative bacteria and fungi. Secondary metabolites 
extracted from 5-day-old cultures of Streptomyces sp. CDRIL-312 [25] 
and Streptomyces spp. [12] exhibited good antifungal activity. 5-day-old 
culture of Streptomyces clavuligerus was reported to produce a good 
yield of clavulanic acid [26] whereas 6-day-old culture of Streptomyces 
sp. 201 exhibited good antimicrobial activity [27].
Impact of pH and temperature on antimicrobial activity
The influence of initial pH on growth and bioactive metabolite production 
of the strain was determined by adjusting the pH of YMD broth from 
4 to10. Maximum growth and antimicrobial metabolite production by 
the strain were found at pH 7 through the strain was able to grow over 
a wide range of pH (Fig. 2). The optimum pH for antibiotic production 
by several actinomycetes was reported to be 7 for Streptomyces 
hygroscopicus D1.5 [28], Streptomyces torulosus KH- 4 [29], Streptomyces 
sp. VITSVK 9[30], Streptomyces cellulosae VJDS-1 [31], Rhodococcus 
erythropolis VLK-12 [32], and A. kerguelensis VL-RK_09 [18].
The yield of bioactive metabolites of the strain was also recorded when 
grown at temperatures of 20-40°C, and the optimum was recorded at 
30°C (Fig. 3). With the rise of incubation temperature from 20 to 30°C, 
there was an increase in bioactive metabolite production. However, 
further, increase in temperature (above 30°C) resulted in the declined 
production of bioactive metabolites. These results are in agreement 
with the earlier reports for Streptomyces [29].
Effect of carbon and nitrogen sources on antimicrobial activity
The effect of various carbon sources on antimicrobial metabolite 
production was tested by supplementing the YMD broth with several 
carbon sources at a concentration of 0.4% (replacing the dextrose) 
while making all other ingredients of the media same and incubated 
for 96 h at 30°C. The effects of carbon sources on the production of 
bioactive metabolites by S. lavendulocolor VHB-9 are presented in 
Fig. 4. Among the carbon sources tested, significant production of 
bioactive metabolites was obtained with lactose followed by sucrose. 
These results are supported by the reports of S. hygroscopicus strains 
AK-111-81 and CH-7, which utilized lactose as a carbon source for high 
antimicrobial metabolite production [33,34]. Since lactose supported a 
high yield of bioactive metabolites, different concentrations of lactose 
(0.5–4%) were tested to determine the optimal concentration. Lactose 
at a concentration of 0.5 % supported the highest yield of bioactive 
metabolites (Fig. 5).
The effect of various nitrogen sources on antimicrobial metabolite 
production was tested by supplementing the YMD broth with several 
nitrogen sources at a concentration of 0.4% to the YMD broth (replacing 
yeast extract). Peptone was found to be good as compared to other 
organic and inorganic nitrogen sources tested (Fig. 6). These results 
are comparable with S. rochei G164 [35] and S. scabies PK-A41 [36]. 
Since peptone enhanced the antimicrobial metabolite production by 
the strain, the effects of different concentrations of peptone were tested 
Fig. 1: Time course of bioactive metabolite production by Streptomyces lavendulocolor VHB-9. The data were statistically analyzed and 
found to be significant at a 5% level
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(Fig. 7). An enhanced level of bioactive metabolite production was 
found with peptone at a concentration of 0.5%. L-asparagine (0.09%) 
was reported as the suitable nitrogen source for optimum production of 
bioactive metabolites by Streptomyces sp. [27] S. rubrolavendulae ICN3 
was reported to exhibit best anti-MRSA and cytotoxic activity when 
glucose and sodium nitrate were amended to the medium as carbon 
and nitrogen sources, respectively [37].
The effect of mineral salts on antimicrobial activity
The effect of mineral salts on secondary metabolite production by the 
strain VHB-9 is shown in Fig. 8. Among the mineral salts tested, K2HPO4 
supported the highest antimicrobial activity. Similar results were 
reported for S. albidoflavus [24] Ripa et al. (2009) and Usha et al. (2011) 
reported that K2HPO4 supported antibiotic production by Streptomyces 
sp. RUPA-08PR and Pseudonocardia spp. [38,39].
Fig. 2: The effect of pH on the bioactive metabolite production by Streptomyces lavendulocolor VHB-9. The data were statistically analyzed 
and found to be significant at a 5% level
Fig. 3: The effect of temperature on the bioactive metabolite production by Streptomyces lavendulocolor VHB-9. The data were statistically 
analyzed and found to be significant at a 5% level
Fig. 4: The effect of carbon sources supplemented in the modified yeast extract-malt extract-dextrose broth on bioactive. Metabolite 
production by Streptomyces lavendulocolor VHB-9. The data were statistically analyzed and found to be significant at a 5% level
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The strain VHB-9 is grown in the optimized fermentation medium 
containing lactose (0.5%), peptone (0.5%), K2HPO4 (0.05%), and 
CaCO3 (0.2%) with pH adjusted to 7.0 and incubated at 30°C. After 
96 h of incubation, the fermentation broth extracted with ethyl acetate 
exhibited good antimicrobial activity against Gram-positive as well as 
Gram-negative bacteria and fungi (Table 1). Among the bacteria tested, 
B. megaterium was highly sensitive to the metabolites followed by 
B. subtilis, S. aureus, P. aeruginosa, S. flexneri, L. Casei, and L. acidophilus. 
Fig. 5: The effect of different concentrations of lactose as carbon source on antimicrobial activity of Streptomyces lavendulocolor VHB-9. 
The data were statistically analyzed and found to besignificant at a 5% level
Fig. 6: The effect of various nitrogen sources supplemented in the modified yeast extract-malt extract-dextrose broth on the antimicrobial 
activity of Streptomyces lavendulocolor VHB-9. The data were statistically analyzed and found to be significant at a 5% level
Fig. 7: The effect of different concentrations of peptone as nitrogen source on the antimicrobial activity of Streptomyces lavendulocolor 
VHB-9. The data were statistically analyzed and found to be significant at a 5% level
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Among the fungi tested, C. albicans exhibited high sensitivity followed 
by A. niger, A. flavus, F. solani, Penicillium citrinum, F. oxysporum, and 
Alternaria sp.
Isolation, purification, and structural elucidation of active 
metabolites
The culture filtrates (30 L) collected after 96 h of incubation were 
extracted twice with ethyl acetate and concentrated to dryness in 
a Rotavac. The crude dark brown residue (3.0g) thus obtained was 
subjected to silica gel column chromatography. The crude extract was 
applied to a silica gel G column (25 cm ×5 cm, Silica gel, Merck, Mumbai, 
India) for the isolation and purification of bioactive compounds.
Among the fractions collected, two fractions (B1 and B4) collected 
at gradient solvent system of Hexane: ethyl acetate (70–30 v/v and 
90–10 v/v) were analyzed. The B1 fraction was re-chromatographed 
(22 cm × 2.5 cm, Silica gel 100; Merck) to get two pure compounds, B1A 
(25 mg) and B1B (20 mg). The fraction B4, obtained as a mixture was 
analyzed by GC-MS system.
B1A eluted with 30% ethyl acetate appeared as light brown liquid 
soluble in CHCl3, MeOH, DCM, and DMSO. The IR absorption maxima 
Vmax at 3437/cm suggested the presence of functional OH group. In 
ESIMS, the compound showed molecular ions at m/z = 108 inferring 
the molecular weight of C4H28O2 [M+NH3]+. The proton NMR of the 
compound displayed proton signals at δ 3.81 (2H, Qd, J=6.04Hz) due 
to methylene protons bearing hydroxyl group, two exchangeable 
protons at δ 1.93 (br s, OH), at δ 1.67 (br s, OH) and two methyl groups 
at δ 1.15 (6H, d, J=6.04 Hz).13C NMR depicted peaks at δ 70.81(2C) 
and δ 16.90 (2C). (α) D25 = −12.5 (c=1, CHCl3). Based on the spectral 
data and optical rotation, B1A was identified as B1A Fig. 9). This is 
the first report of this compound from S. lavendulocolor VHB-9. The 
second fraction B1B in pure form appeared as brown liquid soluble 
in CHCl3, MeOH, DCM, and DMSO. The IR absorption maxima Vmax at 
1708/cm suggested the presence of the carboxylic group. In ESIMS, the 
compound showed molecular ions at m/z=298 inferring the molecular 
weight of C19H38O2 [M+1]+. The proton NMR of the compound displayed 
signals at δ 1.65–1.55 (30H, m), 1.25–1.99 (m, 2H) for aliphatic 
methylene protons, at δ 2.35 (t, 2H, J=7.2 Hz) for alpha methylene 
protons, at δ 1.25–1.99 (m, 2H) for methylene protons, and at δ 0.82 
(t, 3H, J=6.1 Hz) for methyl protons. 13C NMR depicted peak at δ 180.8 
for the carboxylic group. Based on spectral data, the B1B was identified 
as nonadecanoic acid (B1B) (Fig. 10). This is the first report of this 
compound from the strain VHB-9.
The active nonpolar fraction B4 appeared as light brown was soluble 
in CHCl3, MeOH, DCM, and DMSO. The proton NMR of the compound 
revealed the presence of a mixture of compounds. The components of 
partially purified fourth fraction (B4) were analyzed on Agilent GC-
MS system. The peaks of components in gas chromatography were 
subjected to mass spectral analysis. The spectra were analyzed from the 
Fig. 8: The effect of mineral salts on the antimicrobial activity of Streptomyces lavendulocolor 
Fig. 9: Molecular structure of (2R, 3R)-2, 3-butanediol
Fig. 10: Molecular structure of nonadecanoic acid
Table: 1 Antimicrobial activity of S. lavendulocolor VHB-9 under 
optimized culturing conditions
S. No. Test organisms Zone of inhibition (mm)
1 Staphylococcus aureus 27
2 Bacillus megaterium 31
3 Shigella flexneri 25
4 Bacillus subtilis 28
5 Proteus vulgaris 21
6 Pseudomonas aeruginosa 26
7 Escherichia coli 21
8 Streptococcus mutans 22
9 Vibrio cholera 21
10 Lactobacillus casei 25
11 Lactobacillus acidophilus 23
Fungi
12 Candida albicans 25
13 Aspergillus niger 21
14 Aspergillus flavus 19
15 Fusarium solani 18
16 Fusarium oxysporum 17
17 Penicillium citrinum 18
18 Alternaria sp. 17
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available library data NIST MS search (ver. 2.0) (Included with NIST’02 
mass spectral library, Agilent p/n G 1033 A).
Compounds present in partially purified fraction were tentatively 
identified. The GC analysis revealed the presence of 20 compounds 
(Fig. 11). The list of compounds with their retention times is listed in 
Table 2.
Biological assay
MICs of compounds B1A, B1B, and B4 obtained from the strain against 
different microorganisms including bacteria and fungi in terms of 
Fig. 11: Gas chromatographic spectrum of fraction B4 produced by Streptomyces lavendulocolor VHB-9
Table 2. List of compounds obtained from GC-MS analysis of fraction B4 produced by S. lavendulocolor VHB-9
Peak No. Compound name Area Retention time Percent match
1 2-Ethoxy pentane 13.05 3.30 38
2 Methoxy acetic acid 14.19 3.60 43
3 Pentanoic acid 13.60 3.97 52
4 Propanoic acid 1.47 4.56 25
5 Benzene acetic acid 4.57 4.66 25
6 Phenol, 2,4-bis-(1,1-dimethylethyl) 3.97 5.22 96
7 2,2-Diisopropyl1-1,3Dioxolane 1.02 5.60 35
8 Z-8-Hexadecene 3.96 6.14 86
9 Hexadecene 4.50 6.24 90
10 4-Ethynyl-4-vinyl-1,6-heptadecene 9.10 7.03 25
11 6-Methylquinoline 1-oxide 3.11 7.45 38
12 2-Phenylpent-4-enol 12.44 7.83 12
13 5-Octadecene 1.25 8.20 99
14 Octadecane 0.83 8.30 93
15 n-Hexadecanoic acid 4.43 9.84 98
16 1-Tricosanol 0.52 10.20 91
17 Cis-9-Hexadecenal 1.90 11.52 91
18 13-Docsenamide 2.47 16.56 93
19 Stigmastan-3,5-diene 1.26 19.23 91
20 No match found 2.36 25.59 -
GC-MS: Gas chromatography-mass spectroscopy, S. lavendulocolor: Streptomyces lavendulocolor
Test organism B1A MIC (µg/ml)
B1B B4 (PPF†) Positive 
control#
Fusarium oxysporum 90 75 100 10
Fusarium solani 90 65 125 10
Penicillium citrinum 100 75 125 10
*MIC: Minimum inhibitory concentration, #Positive control: Tetracycline 
against bacteria, Griseofulvin against yeast and Carbendazim against fungi. 
B1A: (2R, 3R)-2, 3-Butanediol, B1B: Nonadecanoic acid, B4: PPF, PPF: Public 
provident fund, S. lavendulocolor: Streptomyces lavendulocolor
Table 3: (Continued)
Test organism B1A MIC (µg/ml)
B1B B4 (PPF†) Positive 
control#
Bacteria
Bacillus megaterium 65 40 75 30
Bacillus subtilis 75 55 80 40
Serratia marcescens 90 60 100 25
Xanthomonas campestris 75 65 85 40
Proteus vulgaris 100 80 100 50
Pseudomonas aeruginosa 70 55 75 40
Escherichia coli 90 60 95 25
Enterococcus faecalis 95 75 100 25
Streptococcus mutans 75 55 90 30
Lactobacillus casei 85 55 100 25
Lactobacillus acidophilus 80 55 95 25
Staphylococcus aureus 65 50 80 25
Yeast
Candida albicans 85 55 100 50
Fungi
Aspergillus niger 90 55 125 5
Aspergillus flavus 80 70 100 10
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MIC are shown in Table 3. B1B is more effective than B1A and B4. 
B. megaterium is highly sensitive to the compounds followed by S. 
aureus, B. subtilis, L. acidophilus, and S. mutans among the Gram-positive 
bacteria. P. aeruginosa is highly sensitive to the compounds followed 
by S. marcescens, E. faecalis, X. campestris, E. coli, and P. vulgaris among 
the Gram-negative bacteria. MIC values of B1A B1B, public provident 
fund and tetracycline against the test bacteria varied from 65 to 100 
μg/ml, 40–80 μg/ml, 75–100 μg/ml, and 25–50 μg/ml, respectively. For 
fungi, these values ranged from 90 to 100 μg/ml for B1A, 55–75 μg/ml 
for B1B, 100–125 μg/ml for partially purified fraction, 5–10 μg/ml for 
carbendazim, and 50 μg/ml for griseofulvin. All the compounds showed 
good activity against Candida.
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